Maternal hemodynamics in screen‐positive and screen‐negative women of the ASPRE trial
- 24 May 2019
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 54 (1) , 51-57
Abstract
Objective: To compare maternal hemodynamics and perinatal outcome, in pregnancies that do not develop pre‐eclampsia (PE) or deliver a small‐for‐gestational‐age (SGA) neonate, between those identified at 11–13 weeks' gestation as being screen positive or negative for preterm PE, by a combination of maternal factors, mean arterial pressure, uterine artery pulsatility index, serum placental growth factor and pregnancy associated plasma protein‐A.Methods: This was a prospective longitudinal cohort study of maternal cardiovascular function, assessed using a bioreactance method, in women undergoing first‐trimester screening for PE. Maternal hemodynamics and perinatal outcome were compared between screen‐positive and screen‐negative women who did not have a medical comorbidity, did not develop PE or pregnancy‐induced hypertension and delivered at term a live neonate with birth weight between the 5th and 95th percentiles. A multilevel linear mixed‐effects model was used to compare the repeated measures of cardiac variables, controlling for maternal characteristics.Results: The screen‐negative group (n = 926) had normal cardiac function changes across gestation, whereas the screen‐positive group (n = 170) demonstrated static or reduced cardiac output and stroke volume and higher mean arterial pressure and peripheral vascular resistance with advancing gestation. In the screen‐positive group, compared with screen‐negative women, birth‐weight Z‐score was shifted toward lower values, with prevalence of delivery of a neonate below the 35th, 30th or 25th percentile being about 70% higher, and the rate of operative delivery for fetal distress in labor also being higher.Conclusion: Women who were screen positive for impaired placentation, even though they did not develop PE or deliver a SGA neonate, had pathological cardiac adaptation in pregnancy and increased risk of adverse perinatal outcome. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.Keywords
Funding Information
- Fetal Medicine Foundation (1037116)
This publication has 37 references indexed in Scilit:
- Maternal hemodynamics in normal pregnancy and in pregnancy affected by pre‐eclampsiaUltrasound in Obstetrics & Gynecology, 2018
- Fetal Medicine Foundation fetal and neonatal population weight chartsUltrasound in Obstetrics & Gynecology, 2018
- Maternal hemodynamics early in labor: a possible link with obstetric risk?Ultrasound in Obstetrics & Gynecology, 2018
- Maternal hemodynamics, fetal biometry and Doppler indices in pregnancies followed up for suspected fetal growth restrictionUltrasound in Obstetrics & Gynecology, 2018
- Impact of maternal weight on the intra‐observer and inter‐observer reproducibility of fetal ultrasonography measurements in the third trimesterInternational Journal of Gynecology & Obstetrics, 2017
- Accuracy of competing‐risks model in screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestationUltrasound in Obstetrics & Gynecology, 2017
- Cardiac output assessment in pregnancy: comparison of two automated monitors with echocardiographyUltrasound in Obstetrics & Gynecology, 2017
- Longitudinal maternal hemodynamics in pregnancies affected by fetal growth restrictionUltrasound in Obstetrics & Gynecology, 2016
- Maternal cardiac function in fetal growth‐restricted and non‐growth‐restricted small‐for‐gestational age pregnanciesUltrasound in Obstetrics & Gynecology, 2007
- Abnormal maternal cardiac function precedes the clinical manifestation of fetal growth restrictionUltrasound in Obstetrics & Gynecology, 2004